Project Details
Description
Currently singular vaccines against either PRRSV or PCV2 are available but a bi-valent vaccine against both PRRSV and PCV2 are lacking. The objective of this project is to evaluate the use of non-pahtogenic PCV1 and the vaccine virus PCV1-2 as potential vaccine delivery vectors for the development of a bi-valent vaccine against both PRRSV and PCV2. We expect that the project will validate the use of PCV1 as a useful vaccine delivery vector for other swien pathogens, and we also expect that we will demonstarte that the vaccine virus PCV1-2 can serve as a vaccine delivery vector for creating bi-valent vaccines against other swine viruses.
Status | Finished |
---|---|
Effective start/end date | 7/15/10 → 9/30/19 |
Funding
- National Science Foundation: US$269,999.00
ASJC Scopus Subject Areas
- Electrical and Electronic Engineering
- Materials Science(all)
- Immunology
- Virology
- Pulmonary and Respiratory Medicine
- Agronomy and Crop Science
- Food Science
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.